The Valens Company and High12 Launch DAIZE Premium Vape Cartridges

KELOWNA, BC, Oct. 29, 2020 /CNW/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company”),a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced the launch of 510 vape cartridges under a custom manufacturing agreement with High12 Brands (“High12”) for its newly-introduced DAIZE brand. The DAIZE brand line of vape productsContinue reading “The Valens Company and High12 Launch DAIZE Premium Vape Cartridges”

The Valens Company Reports Financial Results for the Third Quarter of Fiscal 2020

KELOWNA, BC, Oct. 14, 2020 /CNW/ – The Valens Company Inc.  (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to report its third quarter financial results for the period ended August 31, 2020. Key Financial Highlights Net revenue for the third quarter of 2020 was $18.1 million, aContinue reading “The Valens Company Reports Financial Results for the Third Quarter of Fiscal 2020”

The Valens Company to Hold Conference Call to Discuss Financial Results for the Third Quarter of 2020

KELOWNA, BC, Oct. 6, 2020 /CNW/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce it will issue its third quarter 2020 financial results, for the period ended August 31, 2020 on Wednesday, October 14, 2020, after markets close. CONFERENCE CALLContinue reading “The Valens Company to Hold Conference Call to Discuss Financial Results for the Third Quarter of 2020”

The Valens Company Manufactures Record Number of Product SKUs in the Third Quarter of Fiscal 2020

– The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company”),a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced that 56 white label and custom manufacturing product SKUs were produced in the third quarter of 2020, a 56% increase from 36 SKUs in the second quarter of 2020.Continue reading “The Valens Company Manufactures Record Number of Product SKUs in the Third Quarter of Fiscal 2020”

The Valens Company Granted Health Canada Research Licence to Conduct Human Administration Trials for Sensory and Taste Evaluation of Products

KELOWNA – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced that it has received its Cannabis Research Licence under Health Canada’s Cannabis Act and Cannabis Regulations through its wholly-owned subsidiary, Valens Agritech Ltd. This licence permits The Valens Company to conduct research involvingContinue reading “The Valens Company Granted Health Canada Research Licence to Conduct Human Administration Trials for Sensory and Taste Evaluation of Products”

The Valens Company and Verse Cannabis Roll Out Vape Cartridges, CBD Oil, and Hydrocarbon-Derived Crumble in Various Provinces

 – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced the rollout of various new products as part of a custom manufacturing agreement with Verse Cannabis (“Verse”), a group of innovators focused on bringing to market cutting-edge product formulationsContinue reading “The Valens Company and Verse Cannabis Roll Out Vape Cartridges, CBD Oil, and Hydrocarbon-Derived Crumble in Various Provinces”

The Valens Company Reports Financial Results for the Second Quarter of Fiscal 2020

– The Valens Company Inc.  (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company“), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to report its second quarter financial results for the period ended May 31, 2020. Key Financial Highlights of the Second Quarter of 2020 Revenue for the second quarter of 2020 was $17.6Continue reading “The Valens Company Reports Financial Results for the Second Quarter of Fiscal 2020”

The Valens Company Announces Participation in First-of-its-Kind Real-World Evidence Study on Medical Cannabis Led by the University Health Network in Partnership with Shoppers Drug Mart

 –The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company“), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced its participation in a Medical Cannabis Real-World Evidence Study (the “MC-RWE Study“) led by Dr. Hance Clarke of the University Health Network (UHN) in Toronto, Canada. The study will explore theContinue reading “The Valens Company Announces Participation in First-of-its-Kind Real-World Evidence Study on Medical Cannabis Led by the University Health Network in Partnership with Shoppers Drug Mart”

The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2020

– The Valens Company Inc. (formerly Valens GroWorks Corp.) (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce it will issue its second quarter 2020 financial results, for the period ended May 31, 2020, on Wednesday, July 15, 2020, after markets close. CONFERENCE CALLContinue reading “The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2020”